Last Posted: Jun-24-2019 11AM
Last Posted: Jun 24, 2019
- The Revised College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Guideline: A Step Forward for Molecular Cytopathology.
Aisner Dara L et al. Archives of pathology & laboratory medicine 2018 142(6) 684-685 - Challenges of Providing Concordant Interpretation of Somatic Variants in Non-Small Cell Lung Cancer: A Multicenter Study.
Gao Peng et al. Journal of Cancer 2019 10(8) 1814-1824 - The Role of Circulating Tumor DNA in Lung Cancer: Mutational Analysis, Diagnosis, and Surveillance Now and into the Future.
Scilla Katherine A et al. Current treatment options in oncology 2019 Jun 20(7) 61 - Comprehensive genomic profiling of small cell lung cancer in Chinese patients and the implications for therapeutic potential.
Hu Jing et al. Cancer medicine 2019 Jun - Targeted methods for molecular characterization of EGFR mutational profile in lung cancer Moroccan cohort.
Kaanane Houda et al. Gene 2019 Jul 70536-43 - Validity of an NGS-based multiple gene panel in identifying actionable mutations for patients with NSCLC in a Chinese hospital.
Cao Wei et al. Oncology letters 2019 Jun 17(6) 5425-5434 - Precision oncology in non-small-cell lung cancer: opportunities and challenges.
Kim Chul et al. Nature reviews. Clinical oncology 2018 15(6) 348-349 - Clinical outcomes of non-small-cell lung cancer patients with BRAF mutations: results from the French Cooperative Thoracic Intergroup biomarkers France study.
Couraud Sébastien et al. European journal of cancer (Oxford, England : 1990) 2019 Jun 11686-97 - Digital PCR-Based Detection of EGFR Mutations in Paired Plasma and CSF Samples of Lung Adenocarcinoma Patients with Central Nervous System Metastases.
Huang Ruofan et al. Targeted oncology 2019 Jun - Mutational profile of non-small cell lung cancer patients: Use of next-generation sequencing.
Reis D et al. Pulmonology 2019 Jun
.png)
No hay comentarios:
Publicar un comentario